Michael Z. Lin, Associate Professor, Stanford University
Michael Z. Lin describes the basic biology of coronaviruses and the disease COVID-19, projections for the current epidemic, and reviews medications currently in clinical trials.
Michael Lin received an A.B. summa cum laude in Biochemistry from Harvard in 1994, a PhD in Biological and Biomedical Sciences from Harvard Medical School in 2002, and a MD degree from UCLA in 2004. Dr. Lin then received postdoctoral training with Chemistry Nobel Laureate Roger Y. Tsien at UCSD. Dr. Lin was appointed Assistant Professor of Pediatrics and Bioengineering at Stanford in 2009, and Associate Professor of Neurobiology and Bioengineering in 2015.
At Stanford, Dr. Lin leads a research group developing protein-based tools for imaging and controlling biological processes. Among these are methods adapting antiviral drugs and viral proteases to control protein stability and contruct synthetic signaling circuits.
Dr. Lin is a recipient of a Burroughs Wellcome Career Award for Medical Scientists, a Rita Allen Scholar Award, a Damon Runyon-Rachleff Innovation Award, the NIH Pioneer Award, and the World Molecular Imaging Society Roger Y. Tsien Award.